Obesity Nutritional, Metabolic, Endocrine
Conditions
Interventions
At the start of the study, the cutaneous microvascular function of all participants are assessed. Obese adolescents also undergo body composition, metabolic profile and aerobic fitness assessments. T
Sponsors
Saint-Pierre University Hospital, Pediatric Institute (SSR Institut St Pierre)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Obese adolescents, male or female, aged 12-16 years, non-smokers, not taking any medications and without known cardiovascular or metabolic disease 2. Healthy normal-weight pubertal stage-matched adolescents
Exclusion criteria
Exclusion criteria: 1. Smokers 2. Adolescents who participated in extra-school sport activities more than 2h per week
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cutaneous blood flux (CBF) was determined by means of laser Doppler flowmetry (Periflux PF 5000, Perimed, Stockholm, Sweden) equipped with a thermostatic LDF probe (PF 481, Perimed, Stockholm, Sweden), on the volar surface of the right forearm. Assessed at baseline in obese adolescents and controls, and after 3 months of intervention only in obese adolescents. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Body composition, assessed only in obese adolescents at inclusion and after 3 months of intervention 2. Aerobic fitness (including the 20-meter shuttle run test), assessed only in obese adolescents at inclusion and after 3 months of intervention 3. Weight and height measurements were performed and body mass index (BMI) was calculated as weight in kilograms divided by height in squared meters (kg.m-2), at baseline and after 3 months of intervention 4. Body fat mass, abdominal and gluteal fat masses and lean body mass, assessed in only obese adolescents using dual-energy X-ray absorptiometry (DEXA), (QDR 2000 – Discovery, Hologic, Bedford, MA), at baseline and after 3 months of intervention 4. Plasma glucose, plasma insulin and lipid profile were assessed only in obese adolescents using fasting blood samples, at baseline and after 3 months of intervention | — |
Countries
France
Outcome results
None listed